308 related articles for article (PubMed ID: 6547209)
1. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.
Rabbitts TH; Forster A; Hamlyn P; Baer R
Nature; 1984 Jun 14-20; 309(5969):592-7. PubMed ID: 6547209
[TBL] [Abstract][Full Text] [Related]
2. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
3. Allele-specific activation of the c-myc gene in an atypical Burkitt's lymphoma carrying the t(2;8) chromosomal translocation 250 kb downstream from c-myc.
Tachibana K; Takayama N; Matsuo K; Kato S; Yamamoto K; Ohyama K; Umezawa A; Takano T
Gene; 1993 Feb; 124(2):231-7. PubMed ID: 8444346
[TBL] [Abstract][Full Text] [Related]
4. Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region.
Showe LC; Ballantine M; Nishikura K; Erikson J; Kaji H; Croce CM
Mol Cell Biol; 1985 Mar; 5(3):501-9. PubMed ID: 3921823
[TBL] [Abstract][Full Text] [Related]
5. The translocated c-myc oncogene of Raji Burkitt lymphoma cells is not expressed in human lymphoblastoid cells.
Nishikura K; Erikson J; ar-Rushdi A; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 1985 May; 82(9):2900-4. PubMed ID: 3857623
[TBL] [Abstract][Full Text] [Related]
6. NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.
Ji L; Arcinas M; Boxer LM
Mol Cell Biol; 1994 Dec; 14(12):7967-74. PubMed ID: 7969136
[TBL] [Abstract][Full Text] [Related]
7. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
8. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells.
Croce CM; Erikson J; ar-Rushdi A; Aden D; Nishikura K
Proc Natl Acad Sci U S A; 1984 May; 81(10):3170-4. PubMed ID: 6328505
[TBL] [Abstract][Full Text] [Related]
9. Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals.
Hartl P; Lipp M
Mol Cell Biol; 1987 Jun; 7(6):2037-45. PubMed ID: 3110600
[TBL] [Abstract][Full Text] [Related]
10. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.
Spencer CA; LeStrange RC; Novak U; Hayward WS; Groudine M
Genes Dev; 1990 Jan; 4(1):75-88. PubMed ID: 2307371
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma.
Ji L; Arcinas M; Boxer LM
J Biol Chem; 1995 Jun; 270(22):13392-8. PubMed ID: 7768941
[TBL] [Abstract][Full Text] [Related]
12. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
13. Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation.
Eick D; Bornkamm GW
EMBO J; 1989 Jul; 8(7):1965-72. PubMed ID: 2551669
[TBL] [Abstract][Full Text] [Related]
14. Transcription-independent repair of nitrogen mustard-induced N-alkylpurines in the c-myc gene in Burkitt's lymphoma CA46 cells.
Wassermann K; O'Connor PM; Jackman J; May A; Bohr VA
Carcinogenesis; 1994 Sep; 15(9):1779-83. PubMed ID: 7923569
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
Smith-Sørensen B; Hijmans EM; Beijersbergen RL; Bernards R
J Biol Chem; 1996 Mar; 271(10):5513-8. PubMed ID: 8621409
[TBL] [Abstract][Full Text] [Related]
16. Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability.
Rabbitts PH; Forster A; Stinson MA; Rabbitts TH
EMBO J; 1985 Dec; 4(13B):3727-33. PubMed ID: 4092694
[TBL] [Abstract][Full Text] [Related]
17. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of translocated and normal c-myc oncogenes in hybrids between Daudi and lymphoblastoid cells.
Croce CM; Erikson J; Huebner K; Nishikura K
Science; 1985 Mar; 227(4691):1235-8. PubMed ID: 3856319
[TBL] [Abstract][Full Text] [Related]
19. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
20. Breakage on chromosome 2 brings the Ck gene to a region 3' of c-myc in a Burkitt's lymphoma line carrying a (2;8) translocation.
Malcolm S; Davis M; Rabbitts TH
Cytogenet Cell Genet; 1985; 39(3):168-72. PubMed ID: 3930155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]